Global Hemoglobin A1c Monitoring Industry
QuoTest Eyes the US Market III-3
QuoLab - A Cost Effective HbA1c Solution for Developing
Competitive Landscape III-4US Near Patient HbA1c Testing - A Highly Consolidated Market III-4 Diabetes in the US III-5 Highlights III-5 The Statistics III-6 Age Factor III-6 Table 10: US Diabetes Statistics (2010): Number of Diabetics and % Prevalence by Age Group -20 -39 Years, 45-59 Years, and 60 - 79 Years (includes corresponding Graph/Chart) III-6 Diabetes Risk Among Young Native Americans III-6 Mean HbA1c Scores at National Level III-7 Prevalence by Race/Ethnicity III-7 Table 11: US Market for Diabetes (2010): Percentage Breakdown of Prevalence by Race/Ethnicity- Non-Hispanic Blacks and Non-Hispanic Whites (includes corresponding Graph/Chart) III-7 North American Diabetic Prevalence Data III-8 Table 12: North American and Caribbean Regional Population and Diabetes Prevalence Statistics (2010 Estimates) - Top Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (Male and Female) (includes corresponding Graph/Chart) III-8 Table 13: North American and Caribbean Diabetes and Population Statistics (2010 & 2030) III-9 Product Approvals/Launches III-9 Strategic Corporate Developments III-11 Select Key Players III-13 B.Market Analytics III-17 Table 14: US Recent Past, Current and Future Analysis for HbA1c Monitoring by Test Type - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Million or Years 2010 through 2018 (includes corresponding Graph/Chart) III-17 Table 15: US Historic Review for HbA1c Monitoring by Test Type - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart) III-18 Table 16: US 15-Year Perspective for HbA1c Monitoring by Test Type - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2004, 2011 and 2018 (includes corresponding Graph/Chart) III-19
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV